| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/09/2003 | EP1034255A4 Lineage restricted glial precursors from the central nervous system |
| 04/09/2003 | EP0977580B1 MATERIALS AND METHODS RELATING TO INHIBITING THE INTERACTION OF p53 AND mdm2 |
| 04/09/2003 | EP0825998B1 Preparation of immunoglobulin |
| 04/09/2003 | EP0795608B1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 04/09/2003 | EP0779933B1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 04/09/2003 | EP0708831B1 Cell-density enhanced protein tyrosine phosphatases |
| 04/09/2003 | EP0669986B1 Fully impaired consensus kozac sequences for mammalian expression |
| 04/09/2003 | CN1409764A Pseudomonas aeruginosa antigens |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2003 | CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder |
| 04/09/2003 | CN1409114A REG sample protein |
| 04/09/2003 | CN1408874A Procaryotic cell in vivo antibody library construction screening and optimizing of antibody and use |
| 04/09/2003 | CN1408871A Cotton agglutinant protein coding sequence and its use |
| 04/09/2003 | CN1408870A Human transcription factor, its coding sequence preparation and use |
| 04/09/2003 | CN1408866A Human fertilization promotion peptide receptor TCP11 and its coding sequence and preparation and use |
| 04/09/2003 | CN1408860A New human primary azoospermatism relative zinc finger protein and coding sequence and preparation and use |
| 04/09/2003 | CN1408853A Halobiotic dufour algal UDP-glucose dehydrogenase and its coding sequence |
| 04/09/2003 | CN1408852A Halobiotic dufour algal enolase and its coding sequence |
| 04/09/2003 | CN1408724A Novel testicular function relative protein and its use |
| 04/09/2003 | CN1105187C Protocadherin proteins and their use |
| 04/08/2003 | USRE38071 Method for treating infectious respiratory diseases |
| 04/08/2003 | US6545142 Primers; nucleotide sequence |
| 04/08/2003 | US6545141 Brain-specific adapter molecule, gene thereof, and antibody thereto |
| 04/08/2003 | US6545139 Genetic engineering; anticancer agents |
| 04/08/2003 | US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins |
| 04/08/2003 | US6545130 Immunoglobulin that binds to preferential cell surface protein; for use in detection of preferential microorganisms |
| 04/08/2003 | US6544952 Synthesis of glycoconjugates of the globo-H epitope and uses thereof |
| 04/08/2003 | US6544784 Multiple-tumor aberrant growth genes |
| 04/08/2003 | US6544779 Pseudo-type retroviral vectors with modifiable surface capsid proteins |
| 04/08/2003 | US6544767 Genetic engineering; isolated polypeptide |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544758 Methods for expressing endostatin protein |
| 04/08/2003 | US6544754 Oplophorus luciferase subunits |
| 04/08/2003 | US6544749 Antibodies to leukemia inhibitory factor and their use in immunoassays |
| 04/08/2003 | US6544731 Genetic engineering; binding antibodies |
| 04/08/2003 | US6544528 For protecting cats from infection by a broad range of feline leukemia virus |
| 04/08/2003 | US6544516 Treating with anitbodies for bactericidal activity against enterococci |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 04/08/2003 | CA2050300C Tnf-inhibiting proteins and the preparation thereof |
| 04/08/2003 | CA2008368C Soluble molecule related to but distinct from icam-1 |
| 04/08/2003 | CA2006332C Method of detecting neurological disease or dysfunction |
| 04/04/2003 | WO2002030954A1 Method of purifying antibody |
| 04/03/2003 | WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 04/03/2003 | WO2003027289A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027288A1 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 |
| 04/03/2003 | WO2003027287A1 Kidney-specific urate transporter and gene thereof |
| 04/03/2003 | WO2003027285A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | WO2003027284A1 Bone metablic disease markers and utilization thereof |
| 04/03/2003 | WO2003027282A1 Adamts-15, -16, -17, -18 and -19 |
| 04/03/2003 | WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027250A2 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same |
| 04/03/2003 | WO2003027248A2 Antibody inhibitors of gdf-8 and uses thereof |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |
| 04/03/2003 | WO2003027226A2 A method for producing antibody in avian species by intra-muscular injection of coding sequence |
| 04/03/2003 | WO2003027151A1 Recombinant anti-osteopontin antibody and use thereof |
| 04/03/2003 | WO2003027150A1 Antibody and use thereof |
| 04/03/2003 | WO2003027149A1 Antibody and use of the same |
| 04/03/2003 | WO2003027143A2 Gene and protein relating to hepatocellular carcinoma |
| 04/03/2003 | WO2003027138A1 Search for cancer marker by novel screening method |
| 04/03/2003 | WO2003027135A2 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 04/03/2003 | WO2003026705A1 Methods for sterilizing biological materials using flavonoid/flavonol stabilizers |
| 04/03/2003 | WO2003026704A1 Methods of sterilizing biological mixtures using stabilizer mixtures |
| 04/03/2003 | WO2003026703A1 Methods of sterilizing biological materials containing non-aqueous solvents |
| 04/03/2003 | WO2003026692A2 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 04/03/2003 | WO2003026493A2 Diagnosis and treatment of diseases caused by mutations in cd72 |
| 04/03/2003 | WO2003026490A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/03/2003 | WO2003002722A3 T cell regulatory genes and methods of use thereof |
| 04/03/2003 | WO2002092016A3 Therapeutic use of rank antagonists |
| 04/03/2003 | WO2002081523A3 Method for preparing and selecting antibodies |
| 04/03/2003 | WO2002078612A3 Thrombopoietin (tpo) synthebody for stimulation of platelet production |
| 04/03/2003 | WO2002078520A3 IL-1ss INHIBITION FOR MYELOMA AND RELATED DISORDERS |
| 04/03/2003 | WO2002070559A3 Nuclear hormone receptor ligand binding domains |
| 04/03/2003 | WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES |
| 04/03/2003 | WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/03/2003 | WO2002042444A8 Fungal gene cluster associated with pathogenesis |
| 04/03/2003 | WO2002024909A9 Receptor nucleic acids and polypeptides |
| 04/03/2003 | WO2002022166A9 Tweak receptor agonists as anti-angiogenic agents |
| 04/03/2003 | WO2002014369A9 Human kininogen d5 domain polypeptides and their use |
| 04/03/2003 | WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/03/2003 | WO2002000860A3 Novel proteases |
| 04/03/2003 | US20030065161 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030065159 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030065151 Secreted protein HCEJQ69 |
| 04/03/2003 | US20030065150 Fluorescence-activating antisera and IgG fraction therefrom |
| 04/03/2003 | US20030065143 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030065142 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders |
| 04/03/2003 | US20030065137 Immunological methods to modulate myostatin in vertebrate subjects |
| 04/03/2003 | US20030064950 Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity |
| 04/03/2003 | US20030064947 Polypeptides; induction immunology response; cancer diagnosis |
| 04/03/2003 | US20030064925 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064923 Autoimmune disease; antiarthritic agents; genetic engineering |
| 04/03/2003 | US20030064919 Novel polypeptides and polynucleotides encoding same |
| 04/03/2003 | US20030064916 Antigen peptides; medical diagnosis |
| 04/03/2003 | US20030064510 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity |
| 04/03/2003 | US20030064491 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents |
| 04/03/2003 | US20030064482 Preparation of antiproliferative agent; obtain chemical intermediates, insert into reaction mixture, heat, remove protective groups, recover antiproliferative agent |
| 04/03/2003 | US20030064481 Soluble protein for use in treatment of allergenic and autoimmune diseases |
| 04/03/2003 | US20030064480 Soluble fusion protein for use in the treatment of blood, liver and kidney disorders |